Event Details Site - Investor Navigation Corporate Profile Press Releases Events & Presentations Stock Information Stock Quote & Chart Historic Price Lookup Analyst Coverage Financial Filings SEC Filings Governance Documents & Charters Committee Composition Resources Investor FAQs Investor Email Alerts 83rd Annual Society for Investigative Dermatology (SID) Meeting May 15, 2026 Supporting Materials Oral Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 5.1 MB Poster Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 2.5 MB
83rd Annual Society for Investigative Dermatology (SID) Meeting May 15, 2026 Supporting Materials Oral Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 5.1 MB Poster Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 2.5 MB
Oral Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 5.1 MB
Poster Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 2.5 MB
